Please assess the completion status of the following clinical trial:

Trial Title: Exercise for Better Bones - Day or Night?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Postmenopausal women within 1-10 yr after menopause~* BMI 18.5-29.9 kg/m2~* Healthy as determined by a screening physical examination and blood chemistry related to thyroid, liver, kidney, and lipid profile within normal range~* No osteoporosis as determined by dual energy x-ray absorptiometry (DEXA) scan at femoral neck or total spinal region~* No regular exercise for more than 30 minutes a day on more than 2 days a week and no physically active employment, such as maintenance and repair or delivery worker~* No regular use of medications known to interfere with calcium and bone metabolism from 6 weeks prior to the study to the end of study such as medications for heartburn, reflux, H2 blockers, diuretics, etc. such as antacids, Maalox, Pepcid AC, Nexium, Diuril, etc.~* Weight stable (within 5 lbs change) for at least 3 months prior to the start of the study~* Willing to maintain usual lifestyle and activities including the same wake-sleep schedule (go to sleep between 10:00 p.m. and midnight with an average 6-8 hours of sleep time)~* Refrain from the use of alcohol and nicotine (for example, cigarettes, cigars, and e-cigarettes) for the length of the study~* Able and willing to perform moderate intensity exercise without contraindications as determined by the Physical Activity Readiness Questionnaire~* Willing and able to stop any nutritional supplements including vitamin D supplements and calcium-containing medications (for instance, calcium-carbonate antacids)~* Willing not to use tanning booths during the study or not to travel to locations with a tropical climate two weeks prior to the study or during the washout period~Exclusion Criteria:~* Hypertension with resting blood pressure higher than systolic 140 and diastolic 90 mmHg~* Within past 6 weeks, had nutrition supplements or medications known to affect calcium metabolism and appetite such as Antacids, Megace, antacids, heartburn, reflux, H2 blockers, diuretics, etc.~* Allergy to any food ingredients used in the provided diet~* Any disorders affecting nutrient absorption or metabolism, such as cystic fibrosis, lactose intolerance, celiac disease, etc.~* Any sleep disorders such as sleep apnea or regular use of an over-the-counter melatonin supplement~* Diabetes or taking medications known to affect bone such as Actos, Avandia, Invokana, etc.~* Engaged in moderate to vigorous exercise or regular exercise for more than 30 minutes/day on more than 2 days/week within past 6 weeks~* Repeated non-compliance with completing prescribed exercise sessions~* Within past 6 weeks, used tanning booths or traveled to location with a tropic climate~* Use of antibiotics (Amoxicillin, doxycycline, etc.), nonsteroidal anti-inflammatory drugs (aspirin, Celebrex, etc.), or probiotics (Lactobacillus, Bifidobacterium) within the past 6 weeks~* Irritable bowel syndrome, inflammatory bowel disease, or not having a bowel movement three days or longer

- Gender: FEMALE
- Minimum Age: 45 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Morning Exercise (Type: EXPERIMENTAL): Morning exercise session
- Evening Exercise (Type: EXPERIMENTAL): Evening exercise session

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues